Table 2

Effects of LPS on CamK4−/− DC (n = 6)

MarkerswtCamk4−/−P
Regular medium 
    I-A (MFI) 658 ± 107 538 ± 97 .09 
    CD86 (MFI) 150 ± 57 128 ± 50 .54 
    TNF-α, % 2.3 ± 0.5 2.6 ± 0.6 .46 
    IL-6, % 2.6 ± 0.5 3.0 ± 0.4 .18 
LPS 
    I-A (MFI) 1241 ± 289 938 ± 190 .08 
    CD86 (MFI) 657 ± 159 830 ± 127 .08 
    TNF-α, % 11 ± 3 15 ± 3 .49 
    IL-6, % 13 ± 3 15 ± 6 .48 
MarkerswtCamk4−/−P
Regular medium 
    I-A (MFI) 658 ± 107 538 ± 97 .09 
    CD86 (MFI) 150 ± 57 128 ± 50 .54 
    TNF-α, % 2.3 ± 0.5 2.6 ± 0.6 .46 
    IL-6, % 2.6 ± 0.5 3.0 ± 0.4 .18 
LPS 
    I-A (MFI) 1241 ± 289 938 ± 190 .08 
    CD86 (MFI) 657 ± 159 830 ± 127 .08 
    TNF-α, % 11 ± 3 15 ± 3 .49 
    IL-6, % 13 ± 3 15 ± 6 .48 

Means are plus or minus SD (n = 6).

I-A indicates major histocompatibility complex class II molecules; and IL-6, interleukin-6.

Close Modal

or Create an Account

Close Modal
Close Modal